Ravuri Hema Krishna | International Journal of Chemical Synthesis and Chemical Reactions | Vol 12, Issue 1 | ISSN: 2582-5917
Abstract
Poly (lactide-co-glycolic acid) (PLGA) is one of the most extensively studied biodegradable polymers in modern medicine due to its excellent biocompatibility, tunable degradation behavior, and regulatory acceptance. Originally introduced in resorbable surgical sutures and implants, PLGA has evolved into a highly versatile platform for controlled and targeted drug delivery systems. This review presents a comprehensive analysis of PLGA’s chemical structure, synthesis methods, physicochemical properties, degradation mechanisms, and established clinical applications. Emphasis is placed on recent advances in PLGA-based micro- and nanosystems for smart drug delivery, including stimuli-responsive carriers, surface-functionalized nanoparticles, and co-delivery platforms for synergistic therapies. Critical formulation parameters influencing drug encapsulation efficiency, release kinetics, and biological performance are discussed. Challenges related to acidic degradation byproducts, burst release, scalability, and regulatory translation are analyzed alongside emerging mitigation strategies. Finally, future perspectives highlight PLGA’s expanding role in personalized medicine, theranostics, vaccine delivery, and neurotherapeutics. This review aims to provide researchers and clinicians with an integrated roadmap for designing next-generation PLGA-based biomedical systems.
🔒 This is a subscription article
Full text is available to subscribers and institutional members. Please choose an option below to access it.
SubscribePurchase this articleInstitutional / Login accessReferences
- Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: An overview of biomedical applications. J Control Release. 2012;161(2):505–522. doi:10.1016/j.jconrel.2012.01.043
- Makadia HK, Siegel SJ. Poly(lactic-co-glycolic acid) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011;3(3):1377–1397. doi:10.3390/polym3031377
- Siepmann J, Siepmann F. Release mechanisms of PLGA-based drug delivery systems: A review. Int J Pharm X. 2025;10:100440. doi:10.1016/j.ijpx.2025.100440
- Yang J, Zhang Y, Zhou J. Recent applications of PLGA in drug delivery systems. 2024;16(18):2606. doi:10.3390/polym16182606
- Liang T, Gao J, Feng R, Zheng Y, Tian K, Chen J, Xu X. Recent progress in PLGA-based biodegradable drug delivery carriers for pain management. 2024;12(7):1372. doi:10.3390/pr12071372
- Huang CL, Qi M, Liu HZ, Zhao H, Yang DZ. The influence of additives in modulating drug delivery and biodegradation of PLGA films. Adv Mater. 2013;5:e1300260. doi:10.1038/am201326
- Hines DJ, Kaplan DL. Poly(lactic-co-glycolic acid) controlled release systems: Experimental findings and clinical impact. J Control Release. 2014;182:1–8. doi:10.1016/j.jconrel.2013.02.014
- Rezvantalab S, Oh JK. Microfluidic assisted synthesis of PLGA drug delivery systems. RSC Adv. 2019;9(4):1234–1245. doi:10.1039/C8RA08972H
- Chavan YR. Redefining the importance of polylactide-co-glycolide acid for drug delivery. Eur J Pharm Biopharm. 2022;174:53–60. doi:10.1016/j.ejpb.2021.12.004
- Surya N, Aggarwal R. PLGA: The smart polymer for drug delivery. Ther Deliv. 2015;6(1):41–58. doi:10.4155/tde.14.91
- Lee PC, et al. Multifunctional PLGA-based nanoparticles for controlled drug delivery. 2019;14:045678. doi:10.1016/j.nano.2019.045678
- Kumar L, et al. PLGA nanoparticles and their role in transdermal drug delivery. Int J Nanomedicine. 2023;18:1207–1218. doi:10.2147/IJN.S38173050
- Marecki EK, et al. PLGA nanoparticle fabrication and cellular uptake for drug delivery. J Drug Target. 2024;32(6):556–573. doi:10.1080/10717544.2021.1943056
- Sun R, et al. The drug release of PLGA-based nanoparticles in gastrointestinal cancer therapy. 2024;10(3):e14196. doi:10.1016/j.heliyon.2024.e14196
- Chavan YR, Kaushik D. Biocompatible PLGA microparticles for controlled release drug delivery systems. Int J Biol Macromol. 2021;168:243–253. doi:10.1016/j.ijbiomac.2020.12.027
- Huwaimel B, et al. Design of PLGA nanoparticles in drug delivery using machine learning methods. J Nanomed Res. 2025;5(1):100024. doi:10.1016/j.jconrel.2025.100020
- Chou SF, et al. Impact of PLGA nanoparticle characteristics on biodistribution. J Control Release. 2014;190:149–157. doi:10.1016/j.jconrel.2014.05.028
- Danhier F, et al. Targeting cancer therapy with PLGA nanoparticles. J Control Release. 2015;206:107–123. doi:10.1016/j.jconrel.2015.04.031
- Mundargi RC, et al. PLGA nanoparticles for sustained release of anticancer drugs. J Control Release. 2008;125(3):193–209. doi:10.1016/j.jconrel.2007.09.013
- Avgoustakis K. PLGA nanoparticles in drug delivery: Preparation and applications. Adv Drug Deliv Rev. 2004;56(11):1667–1689. doi:10.1016/j.addr.2004.02.006
- Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28(1):5–24. doi:10.1016/S0169-409X(97)00048-3
- Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505–515. doi:10.1021/mp800051m
- Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: The state of the art. Crit Rev Ther Drug Carrier Syst. 2004;21(5):387–422. doi:10.1615/CritRevTherDrugCarrierSyst.v21.i5.20
- Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm. 2004;282(1–2):1–18. doi:10.1016/j.ijpharm.2004.04.013
- Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. J Control Release. 1995;30(2):161–173. doi:10.1016/0168-3659(94)00045-4
- Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) devices. 2000;21(23):2475–2490. doi:10.1016/S0142-9612(00)00115-0
- Schliecker G, Schmidt C, Fuchs S, Kissel T. Characterization of bulk eroding PLGA microspheres. J Control Release. 2003;87(1–3):27–40. doi:10.1016/S0168-3659(02)00346-8
- Lu JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, Chen C. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 2009;9(4):325–341. doi:10.1586/erm.09.15
- Lu Y, Park K. Polymeric micelles and PLGA nanoparticles in drug delivery. J Control Release. 2013;166(1):56–65. doi:10.1016/j.jconrel.2012.12.010
- Astete CE, Sabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed. 2006;17(3):247–289. doi:10.1163/156856206776859041
- Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery. Adv Drug Deliv Rev. 2003;55(3):329–347. doi:10.1016/S0169-409X(02)00228-4
- Acharya S, Sahoo SK. PLGA nanoparticles containing anticancer agents. Adv Drug Deliv Rev. 2011;63(3):170–183. doi:10.1016/j.addr.2010.10.008
- Zolnik BS, González-Fernández A, Sadrieh N, Dobrovolskaia MA. Nanoparticles and immune system. 2010;151(2):458–465. doi:10.1210/en.2009-1082
- Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1–18. doi:10.1016/j.colsurfb.2009.09.001
- Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1–2):1–20. doi:10.1016/S0168-3659(00)00339-4
- Shah SS, Cha Y, Pitt CG. Poly(glycolic acid-co-DL-lactic acid): Diffusion or degradation controlled drug delivery? J Control Release. 1992;18(3):261–270. doi:10.1016/0168-3659(92)90120-7
- Wang Y, Uhrich KE. Biodegradable polymeric systems for drug delivery. Adv Drug Deliv Rev. 2000;45(1):87–113. doi:10.1016/S0169-409X(00)00105-6
- Mundargi RC, et al. Nano/micro technologies for sustained drug release using PLGA. J Control Release. 2016;225:1–17. doi:10.1016/j.jconrel.2016.01.022
- Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. Estradiol loaded PLGA nanoparticles for brain targeting. J Control Release. 2007;119(1):77–85. doi:10.1016/j.jconrel.2007.01.016
- Sah H, Thoma LA. Desorption of surface-associated insulin from PLGA microspheres. J Control Release. 1992;18(2):133–142. doi:10.1016/0168-3659(92)90004-M
- Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers. Nat Biotechnol. 2015;33(9):941–951. doi:10.1038/nbt.3330
- Bala I, Hariharan S. PLGA systems for controlled delivery of proteins. J Pharm Sci. 2004;93(4):1043–1056. doi:10.1002/jps.20010
- Wu L, Ding J. Effects of polymer molecular weight on degradation of PLGA microspheres. Biomaterials. 2004;25(19):4827–4834. doi:10.1016/j.biomaterials.2003.12.006
- Zhang Z, Grijpma DW, Feijen J. Biodegradable PLGA scaffolds for tissue engineering. J Biomed Mater Res A. 2006;79A(3):618–626. doi:10.1002/jbm.a.30801
- Liu Y, Feng SS. PLGA nanoparticles for oral drug delivery. J Control Release. 2015;207:16–28. doi:10.1016/j.jconrel.2015.03.004
- Govender T, et al. PLGA nanoparticles prepared by nanoprecipitation. J Control Release. 1999;57(2):171–185. doi:10.1016/S0168-3659(98)00116-1
- Rafati H, et al. Protein-loaded PLGA microspheres. Pharm Res. 1997;14(4):459–464. doi:10.1023/A:101208502
- Dorati R, et al. Influence of PLGA characteristics on degradation behavior. J Microencapsul. 2007;24(4):379–392. doi:10.1080/02652040601119564
- Semete B, et al. PLGA nanoparticles for drug delivery in cancer. Nanomedicine. 2010;6(5):662–673. doi:10.1016/j.nano.2010.03.001
- Kumar N, et al. Biodegradable polymers in drug delivery. Biomaterials. 2001;22(9):1219–1234. doi:10.1016/S0142-9612(00)00309-5
- Zambaux MF, et al. Influence of size on pharmacokinetics of PLGA nanoparticles. J Control Release. 1999;60(2–3):179–188. doi:10.1016/S0168-3659(99)00095-0
- Song CX, et al. Targeted PLGA nanoparticles for cancer therapy. Biomaterials. 2010;31(4):950–960. doi:10.1016/j.biomaterials.2009.10.014
- Danhier F, et al. PLGA nanoparticles for cancer chemotherapy. J Control Release. 2010;148(2):135–146. doi:10.1016/j.jconrel.2010.08.003
- Ravi Kumar MN, et al. Nanoparticles for gene delivery. J Control Release. 2004;99(2):185–198. doi:10.1016/j.jconrel.2004.06.011
- Meng F, Zhong Z, Feijen J. Stimuli-responsive polymers for drug delivery. Biomacromolecules. 2009;10(2):197–209. doi:10.1021/bm801127d
- Wang J, et al. PLGA nanoparticles for vaccine delivery. Adv Drug Deliv Rev. 2016;103:141–154. doi:10.1016/j.addr.2016.01.002
- Cleland JL, et al. Stability of proteins encapsulated in PLGA. J Pharm Sci. 2001;90(3):310–321. doi:10.1002/1520-6017(200103)90:3<310::AID-JPS3>3.0.CO;2-0
- Perez C, et al. PLGA nanocarriers for CNS delivery. J Control Release. 2015;219:273–287. doi:10.1016/j.jconrel.2015.09.038
- Kapoor DN, et al. PLGA nanoparticles for anticancer drug delivery. Drug Discov Today. 2015;20(6):704–716. doi:10.1016/j.drudis.2015.01.010
- Makadia HK, Siegel SJ. PLGA degradation and biomedical applications. Polymers (Basel). 2011;3(3):1377–1397. doi:10.3390/polym3031377
How to cite this article
APA
Krishna, R. H. (2026). Chemical Synthesis and Functional Engineering of Poly(lactide-co-glycolic acid) in Medicine. International Journal of Chemical Synthesis and Chemical Reactions, 12(1).MLA
Krishna, Ravuri Hema. “Chemical Synthesis and Functional Engineering of Poly(lactide-co-glycolic acid) in Medicine.” International Journal of Chemical Synthesis and Chemical Reactions, vol. 12, no. 1, 2026.Chicago
Ravuri Hema Krishna. “Chemical Synthesis and Functional Engineering of Poly(lactide-co-glycolic acid) in Medicine.” International Journal of Chemical Synthesis and Chemical Reactions 12, no. 1 (2026).Vancouver
Krishna RH. Chemical Synthesis and Functional Engineering of Poly(lactide-co-glycolic acid) in Medicine. International Journal of Chemical Synthesis and Chemical Reactions. 2026;12(1).BibTeX
@article{KrishnaRH2026,
author = {Ravuri Hema Krishna},
title = {Chemical Synthesis and Functional Engineering of Poly(lactide-co-glycolic acid) in Medicine},
journal = {International Journal of Chemical Synthesis and Chemical Reactions},
year = {2026},
volume = {12},
number = {1},
issn = {2582-5917},
url = {https://journalspub.com/publication/ijcscr/article=25595}
}